Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Hodgkin Disease × Neoadjuvant Therapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 16 Esophageal Squamous Cell Carcinoma 5 Rectal Neoplasms 4 Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Stomach Neoplasms 3 Colorectal Neoplasms 3 Carcinoma, Hepatocellular 3 Uterine Cervical Neoplasms 2 Sarcoma 2 Ovarian Neoplasms 2 Nasopharyngeal Carcinoma 2 Lung Neoplasms 2 Urinary Bladder Neoplasms 1 Turcot syndrome 1 Surgery 1 Squamous Cell Carcinoma of Head and Neck 1 Squamous Cell Carcinoma of External Auditory Canal 1 Recurrence 1 Peritoneal Neoplasms 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Pancreatic Neoplasms 1 Pancreatic Ductal Adenocarcinoma (PDAC) 1 Pancreatic Ductal Adenocarcinoma 1 Neoplastic Cells, Circulating 1 Neoplasm Metastasis 1 Neoadjuvant Therapy 1 Muscle Invasive Bladder Cancer 1 Multiple Myeloma 1 Margins of Excision 1

Interventions

Cyclophosphamide 10 Nivolumab 7 pembrolizumab 6 fludarabine 6 Gemcitabine 6 Brentuximab Vedotin 6 Etoposide 5 Doxorubicin 5 Dexamethasone 5 Dacarbazine 5 fludarabine phosphate 4 Whole-Body Irradiation 4 Vinblastine 4 Mycophenolic Acid 4 Melphalan 4 Filgrastim 4 Blood Specimen Collection 4 Vinorelbine 3 Specimen Handling 3 Magnetic Resonance Spectroscopy 3 Granulocyte Colony-Stimulating Factor 3 Cytarabine 3 pegfilgrastim 2 X-Rays 2 Vincristine 2 Tacrolimus 2 Stem Cell Transplantation 2 Rituximab 2 Cisplatin 2 Carmustine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04378647 2024-02-26

BRESELIBET

Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea

Phase 2 Recruiting

Hodgkin Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡